Director/PDMR Shareholding

GlaxoSmithKline PLC 16 January 2007 Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons I give below details of changes in the interests of Directors, Persons Discharging Managerial Responsibility or Connected Persons in the Ordinary Shares of GlaxoSmithKline plc. 11 January 2007 The Administrators of the SmithKline Beecham Employee Benefit Trust ("the Trust") notified the Company on 15 January 2007 that 38,040 Ordinary shares had been transferred from the Trust to a participant in the SmithKline Beecham Annual Investment Plan. 12 January 2007 The Trust notified the Company on 15 January 2007 that 380 Ordinary Shares had been acquired by the Trust at a price of £13.70 per share following the re-investment of the dividend paid to the Trust on behalf of participants in the SmithKline Beecham Bonus Investment Plan on 4 January 2007. The Trust also notified the Company on 15 January 2007 that 9,668 Ordinary Shares had been acquired by the Trust at a price of £13.70 per share following the re-investment of the dividend paid to the Trust on behalf of participants in the SmithKline Beecham Annual Investment Plan on 4 January 2007. The Trust is a discretionary fund of which all non US employees or former employees of GlaxoSmithKline plc and its subsidiaries are potential beneficiaries. One of the Company's directors, Mr J S Heslop is therefore interested in the shares held in the fund from time to time in the same way as other non US employees or former employees of GlaxoSmithKline plc and its subsidiaries. This notification relates to a transaction notified in accordance with Disclosure Rule 3.1.4R(1)(b). S M Bicknell Company Secretary 16 January 2007 This information is provided by RNS The company news service from the London Stock Exchange

Companies

GSK (GSK)
UK 100

Latest directors dealings